Biomarker implementation: Evaluation of the decision-making impact of CXCL10 testing in a pediatric cohort.

Caroline LamarcheAtul K SharmaAviva M GoldbergLi WangTom David Blydt-Hansen

Published in: Pediatric transplantation (2020)

There is high variability in decision-making on biopsy indication. Urinary CXCL10/Cr improves probability estimates for risk of rejection. Training may be needed to assist nephrologists in better integrate biomarker information into clinical decision-making.

Keyphrases

decision making
primary care
healthcare
quality improvement
ultrasound guided
social media
young adults